You might have heard the controversy following Dragons Den investing in an alternative medicine that claimed to relieve ME/CFS (chronic fatigue syndrome). Steven Bartlett ultimately sealed the deal with AcuSeed’s founder Giselle Boxer. The decision to invest in an unproven treatment has raised eyebrows and concerns alike from the medical, patient, and investment communities. At the core of this issue is the intersection of hope, desperation, and the allure of a quick fix versus the rigorous demands and ethical responsibilities of scientific validation. Investing in such claims without the backing of solid scientific evidence not only undermines the principles of responsible investment but also risks giving false hope to those in desperate search of relief. This scenario serves as a stark reminder of the importance of distinguishing between genuine scientific breakthroughs and those that are, frankly, not science at all.
Show more